310
M.-L. Han et al. / Tetrahedron: Asymmetry 23 (2012) 306–312
3H), 3.60 (s, 1H), 4.09 (s, 5H), 4.29 (m, 1H), 4.83–4.87 (m, 2H),
6.44–6.48 (m, 2H), 6.52–6.56 (m, 2H), 6.79–6.85 (m, 2H), 6.90–
7.06 (m, 7H), 7.29 (s, 3H), 7.39–7.43 (m, 2H), 7.53 (d, J = 8.0 Hz,
1H); 31P NMR (162 MHz, CDCl3): d ꢀ23.3; 13C NMR (100 MHz,
CDCl3): d 138.2 (d, J = 9.0 Hz), 138.0 (d, J = 10.0 Hz), 137.1, 135.5,
135.3 (d, J = 21.0 Hz), 134.1 (d, J = 2.0 Hz), 131.3 (d, J = 19.0 Hz),
129.8, 128.7, 127.8 (d, J = 8.0 Hz), 127.4, 127.0, 126.7 (d,
J = 6.0 Hz), 126.5, 125.9, 122.4, 121.2, 120.3, 118.9, 110.7, 98.3 (d,
J = 24.0 Hz), 75.5 (d, J = 9.0 Hz), 71.8 (d, J = 5.0 Hz), 70.1 (d,
J = 4.0 Hz), 69.8, 68.0, 31.0 (d, J = 8.0 Hz), 21.0, 20.6; HRMS (m/z)
calcd for C39H34FeNPS: 635.1499, found: 635.1488.
6.78–7.02 (m, 5H), 7.23–7.40 (m, 5H), 7.50 (d, J = 8.0 Hz, 1H); 31P
NMR (162 MHz, CDCl3): d ꢀ23.3; 13C NMR (100 MHz, CDCl3): d
138.1 (d, J = 10.0 Hz), 136.7, 135.2 (d, J = 21.0 Hz), 131.3 (d,
J = 19.0 Hz), 128.6, 127.8 (d, J = 8.0 Hz), 126.7 (d, J = 7.0 Hz),
126.4, 126.3, 126.0, 123.5, 121.9, 120.2, 118.6, 110.4, 98.6 (d,
J = 24.0 Hz), 75.4 (d, J = 9.0 Hz), 71.8 (d, J = 5.0 Hz), 70.2 (d,
J = 4.0 Hz), 69.8, 67.9, 40.1 (d, J = 3.0 Hz), 30.8 (d, J = 7.0 Hz), 24.2,
23.5, 20.7; HRMS calcd for
587.1482.
C35H34FeNPS: 587.1499, found:
4.3. Synthesis of N-tert-butyloxycarbonyl-3-{(S)-1-[(S)-2-
(diphenylphosphino)- ferrocenyl]ethyl}-2-(phenylthio)-
indole (Sc,SFc)-2g
4.2.3. 3-{(S)-1-[(S)-2-(Diphenylphosphino)ferrocenyl]ethyl}-2-
[(4-chlorophenyl)- thio]indole (Sc,SFc)-2c
Yellow solid, 77% yield. Mp = 207–209 °C; ½a D20
ꢁ
¼ ꢀ67:4 (c 0.15,
To a solution of (Sc,SFc)-2a (621.5 mg, 1 mmol) and DMAP
(2.44 mg, 0.02 mmol) in CH2Cl2 (4 mL) was added (Boc)2O
(240.2 mg, 1.1 mmol) and the solution was stirred at room temper-
ature for 2 h. The resulting mixture was evaporated under reduced
pressure and purified by flash column chromatography to afford
the N-Boc-protected ligand (Sc,SFc)-2g. Yellow solid, 80% yield.
CHCl3); 1H NMR (400 MHz, CDCl3): d 1.72 (d, J = 4.0 Hz, 3H), 3.61 (s,
1H), 4.09 (s, 5H), 4.28 (s, 1H), 4.82 (s, 2H), 6.45–6.46 (m, 2H), 6.53–
6.54 (m, 2H), 6.79–6.93 (m, 5H), 7.02–7.13 (m, 4H), 7.29 (s, 3H),
7.41 (s, 2H), 7.54 (d, J = 8.0 Hz, 1H); 31P NMR (162 MHz, CDCl3): d
ꢀ23.4; 13C NMR (100 MHz, CDCl3): d 138.1 (d, J = 7.0 Hz), 137.7
(d, J = 10.0 Hz), 137.3, 136.7, 135.2 (d, J = 21.0 Hz), 131.4 (d,
J = 19.0 Hz), 129.0, 128.8, 128.0, 127.9, 127.8, 126.8 (d, J = 7.0 Hz),
126.6, 125.7, 122.8, 120.6, 119.8, 119.2, 110.9, 98.1 (d,
J = 24.0 Hz), 75.2 (d, J = 5.0 Hz), 71.8 (d, J = 4.0 Hz), 70.1 (d,
J = 4.0 Hz), 69.9, 68.2, 31.1 (d, J = 7.0 Hz), 20.7; HRMS calcd for
Mp = 89–92 °C; ½a 2D0
ꢁ
¼ ꢀ96:9 (c 0.12, CHCl3); 1H NMR (400 MHz,
CDCl3): d 1.35 (s, 9H), 1.63 (d, J = 8.0 Hz, 3H), 3.61 (s, 1H), 4.14 (s,
5H), 4.29 (s, 1H), 4.82 (s, 1H), 5.05–5.10 (m, 1H), 6.56–6.58 (m,
4H), 6.85 (s, 1H), 6.95–6.97 (m, 2H), 7.02–7.07 (m, 2H),7.15–7.19
(m, 3H), 7.30 (s, 3H), 7.43 (s, 2H), 7.51 (d, J = 8.0 Hz, 1H), 7.85 (d,
J = 8.0 Hz, 1H); 31P NMR (162 MHz, CDCl3): d ꢀ23.8; 13C NMR
(100 MHz, CDCl3): d 149.1, 139.8 (d, J = 2.0 Hz), 138.0, 137.6 (d,
J = 11.0 Hz), 137.2 (d, J = 9.0 Hz), 135.0 (d, J = 21.0 Hz), 134.8,
131.5 (d, J = 20.0 Hz), 128.8, 128.6, 127.9 (d, J = 7.0 Hz), 127.0,
126.8 (d, J = 6.0 Hz), 125.4, 124.7 (d, J = 6.0 Hz), 121.8, 121.7,
120.3, 115.6, 97.0 (d, J = 23.0 Hz), 83.2, 76.2 (d, J = 9.0 Hz), 72.1
(d, J = 5.0 Hz), 70.3, 69.9, 67.9, 31.7 (d, J = 6.0 Hz), 27.9, 27.8, 19.6;
HRMS (m/z) calcd for C43H40FeNO2PS: 721.1867, Found: 721.1881.
C38H31ClFeNPS: 655.0953, found: 655.0974.
4.2.4. 3-{(S)-1-[(S)-2-(Diphenylphosphino)ferrocenyl]ethyl}-2-
(benzylthio)indole (Sc,SFc)-2d
Yellow solid, 80% yield. Mp = 69–71 °C; ½a D20
¼ ꢀ239:6 (c 0.12,
ꢁ
CHCl3); 1H NMR (400 MHz, CDCl3): d 1.59 (d, J = 8.0 Hz, 3H), 3.63
(s, 1H), 3.85–3.94 (m, 2H), s1 (s, 5H), 4.29 (d, J = 4.0 Hz, 1H),
4.77–4.83 (m, 2H), 6.38–6.42 (m, 2H), 6.49–6.53 (m, 2H), 6.78–
7.08 (m, 7H), 7.21–7.23 (m, 3H), 7.29–7.30 (m, 3H), 7.42–7.50
(m, 3H); 31P NMR (162 MHz, CDCl3):
(100 MHz, CDCl3):
d
ꢀ22.8; 13C NMR
4.4. General procedure for the catalytic asymmetric 1,3-dipolar
cycloadditon of azomethine ylides
d
139.0, 138.7 (d, J = 9.0 Hz), 138.3 (d,
J = 9.0 Hz), 136.8, 135.4 (d, J = 21.0 Hz), 131.2 (d, J = 18.0 Hz),
129.0, 128.8, 128.5, 127.8 (d, J = 8.0 Hz), 127.1, 126.8 (d,
J = 6.0 Hz), 126.4, 126.1, 125.8, 123.4, 122.0, 120.3, 118.8, 110.5,
98.9 (d, J = 25.0 Hz), 75.3 (d, J = 9.0 Hz), 71.7 (d, J = 4.0 Hz), 70.2
(d, J = 5.0 Hz), 69.8, 68.1, 41.2 (d, J = 4.0 Hz), 31.0 (d, J = 8.0 Hz),
20.7; HRMS calcd for C39H34FeNPS: 635.1499, found: 635.1494.
Under a nitrogen atmosphere, a solution of AgOAc (0.009 mmol)
and ligand 2 (0.0099 mmol) in 1.5 mL of Et2O was stirred at room
temperature for 1 h. Imino esters (0.3 mmol), Et3N (4.2 lL,
0.03 mmol), and dimethyl maleate (0.36 mmol) were added suc-
cessively. Once the starting materials were consumed (monitored
by TLC), the mixture was passed through a short column of silica
gel and the diastereometric ratio (endo/exo) was determined by
NMR spectroscopic analysis after removal of the solvent. The resi-
due was purified by column chromatography on silica gel, and then
submitted to ee analysis by HPLC with a chiral column.
4.2.5. 3-{(S)-1-[(S)-2-(Diphenylphosphino)ferrocenyl]ethyl}-2-
(methylthio)indole (Sc,SFc)-2e
Yellow solid, 81% yield. Mp = 150–152 °C; ½a D20
¼ ꢀ215:0 (c
ꢁ
0.13, CHCl3); 1H NMR (400 MHz, CDCl3): d 1.77 (d, J = 8.0 Hz, 3H),
2.29 (s, 3H), 3.59 (s, 1H), 4.11 (s, 5H), 4.27–4.28 (m,1H), 4.81–
4.84 (m, 2H), 6.37–6.41 (m, 2H), 6.49–6.52 (m, 2H), 6.77–6.80
(m, 1H), 6.86–6.90 (m, 2H), 6.97–7.01 (m, 1H), 7.10 (s, 1H), 7.26–
7.28 (m, 3H), 7.39–7.42 (m, 2H), 7.49 (d, J = 8.0 Hz, 1H); 31P NMR
(162 MHz, CDCl3): d ꢀ23.0; 13C NMR (100 MHz, CDCl3): d 138.3
(d, J = 9.0 Hz), 138.0 (d, J = 10.0 Hz), 136.7, 135.3 (d, J = 21.0 Hz),
131.3 (d, J = 18.0 Hz), 128.7, 127.8 (d, J = 8.0 Hz), 126.6 (d,
J = 6.0 Hz), 126.3, 126.0, 125.1, 124.8, 121.9, 120.1, 118.8, 110.4,
98.5 (d, J = 24.0 Hz), 75.3 (d, J = 8.0 Hz), 71.7 (d, J = 4.0 Hz), 70.1
(d, J = 3.0 Hz), 69.8, 68.0, 30.8 (d, J = 8.0 Hz), 20.9, 19.8; HRMS calcd
for C33H30FeNPS: 559.1186, found: 559.1179.
4.4.1. Trimethyl (2S,3R,4S,5R)-5-(4-chlorophenyl)pyrrolidine-
2,3,4-tricarboxyl- ate endo-9a
White solid, 95% yield (endo/exo = 95/5), 99% ee. ½a D20
¼ þ14:2 (c
ꢁ
0.17, CHCl3). Chiral AS-H column, 40 °C, 205 nm, n-hexane/i-propa-
nol = 50/50, flow rate = 0.8 mL/min, tR = 7.7 and 10.5 min; 1H NMR
(400 MHz, CDCl3): d 7.24 (s, 4H), 4.40 (d, J = 4.0 Hz, 1H), 4.10 (d,
J = 12.0 Hz, 1H), 3.74 (s, 3H), 3.64–3.69 (m, 1H), 3.63 (s, 3H),
3.52–3.54 (m, 1H), 3.22 (s, 3H), 3.03 (br, 1H).
4.4.2. Trimethyl (2S,3R,4S,5R)-5-phenylpyrrolidine-2,3,4-
tricarboxylate endo-9b
4.2.6. 3-{(S)-1-[(S)-2-(Diphenylphosphino)ferrocenyl]ethyl}-2-
(i-propylthio)indole (Sc,SFc)-2f
White solid, 97% yield (endo/exo = 96/4), 91% ee. ½a D20
¼ þ62:1 (c
ꢁ
0.13, CHCl3). Chiral AS-H column, 205 nm, n-hexane/i-propa-
nol = 50/50, flow rate = 0.8 mL/min, tR = 6.5 and 11.4 min; 1H
NMR (400 MHz, CDCl3): d 7.17–7.29 (m, 5H), 4.42 (d, J = 8.0 Hz,
1H), 4.10 (d, J = 8.0 Hz, 1H), 3.74 (s, 3H), 3.64–3.66 (m, 1H), 3.62
(s, 3H), 3.51–3.53 (m, 1H), 3.16 (s, 4H).
Yellow solid, 84% yield. Mp = 120–122 °C; ½a D20
¼ ꢀ248:4 (c
ꢁ
0.12, CHCl3); 1H NMR (400 MHz, CDCl3): d 1.21–1.26 (m, 6H),
1.77 (s, 3H), 3.13–3.18 (m, 1H), 3.55 (s, 1H), 4.12 (s, 5H), 4.26 (s,
1H), 4.77–4.83 (m, 2H), 6.38–6.41 (m, 2H), 6.50–6.54 (m, 2H),